{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:00:27Z","timestamp":1781053227106,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2025\\u201322842969 \/ RS-2025\\u201322852971"],"award-info":[{"award-number":["RS-2025\\u201322842969 \/ RS-2025\\u201322852971"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.leukres.2026.108237","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:41:30Z","timestamp":1776408090000},"page":"108237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Detection of BCR::ABL1-like ALL using RT-PCR, a targeted RNA panel, and RNA sequencing"],"prefix":"10.1016","volume":"166","author":[{"given":"Hanwool","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungok","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myungshin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.leukres.2026.108237_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.leukres.2026.108237_bib2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.leukres.2026.108237_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","article-title":"Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults","volume":"129","author":"Jain","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2026.108237_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High frequency and poor outcome of philadelphia chromosome-like acute lymphoblastic leukemia in adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.leukres.2026.108237_bib5","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/s41409-021-01253-6","article-title":"Non-inferior long-term outcomes of adults with Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"56","author":"Cho","year":"2021","journal-title":"Bone Marrow Transpl."},{"issue":"5","key":"10.1016\/j.leukres.2026.108237_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/cncr.35051","article-title":"A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia","volume":"130","author":"Gupta","year":"2024","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2026.108237_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3324\/haematol.2015.136366","article-title":"Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis","volume":"102","author":"Herold","year":"2017","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.leukres.2026.108237_bib8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2018-04-841676","article-title":"Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group","volume":"132","author":"Roberts","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2026.108237_bib9","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.3324\/haematol.2018.207019","article-title":"BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy","volume":"105","author":"Cario","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.leukres.2026.108237_bib10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/hematology.2022000357","article-title":"Clinical screening for Ph-like ALL and the developing role of TKIs","volume":"2022","author":"Tran","year":"2022","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"23","key":"10.1016\/j.leukres.2026.108237_bib11","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1182\/blood.2020006846","article-title":"Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia","volume":"138","author":"Chang","year":"2021","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2026.108237_bib12","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.3324\/haematol.2013.095372","article-title":"Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion","volume":"98","author":"Lengline","year":"2013","journal-title":"Haematologica"},{"issue":"25","key":"10.1016\/j.leukres.2026.108237_bib13","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1200\/JCO.2012.47.6770","article-title":"Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia","volume":"31","author":"Weston","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108237_bib14","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1186\/s12885-021-08635-5","article-title":"Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia","volume":"21","author":"Walter","year":"2021","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.leukres.2026.108237_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000939","article-title":"The gene expression classifier ALLCatchR identifies B-cell precursor ALL subtypes and underlying developmental trajectories across age","volume":"7","author":"Beder","year":"2023","journal-title":"Hemasphere"},{"issue":"14","key":"10.1016\/j.leukres.2026.108237_bib16","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1182\/bloodadvances.2021005894","article-title":"ALLSorts: an RNA-Seq subtype classifier for B-cell acute lymphoblastic leukemia","volume":"6","author":"Schmidt","year":"2022","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.leukres.2026.108237_bib17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa2312948","article-title":"Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults","volume":"391","author":"Litzow","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.leukres.2026.108237_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood.2024023930","article-title":"Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL","volume":"144","author":"Zhao","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108237_bib19","article-title":"RanBALL: an ensemble machine learning framework for accurate subtype identification of pediatric B-cell acute lymphoblastic leukemia","author":"Li","year":"2025","journal-title":"Adv. Intell. Syst."},{"issue":"6","key":"10.1016\/j.leukres.2026.108237_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jmoldx.2018.06.009","article-title":"OncoKids: a comprehensive next-generation sequencing panel for pediatric malignancies","volume":"20","author":"Hiemenz","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.leukres.2026.108237_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13073-015-0221-8","article-title":"A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases","volume":"7","author":"Miller","year":"2015","journal-title":"Genome Med."},{"issue":"3","key":"10.1016\/j.leukres.2026.108237_bib22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1101\/gr.257246.119","article-title":"Accurate and efficient detection of gene fusions from RNA sequencing data","volume":"31","author":"Uhrig","year":"2021","journal-title":"Genome Res."},{"issue":"24","key":"10.1016\/j.leukres.2026.108237_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1186\/s12859-019-3247-x","article-title":"A protocol to evaluate RNA sequencing normalization methods","volume":"20","author":"Abrams","year":"2019","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.leukres.2026.108237_bib24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.37349\/etat.2022.00102","article-title":"Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples","author":"Capone","year":"2022","journal-title":"Explor Target Antitumor Ther."},{"issue":"12","key":"10.1016\/j.leukres.2026.108237_bib25","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.jmoldx.2021.08.009","article-title":"Clinical implications of a targeted RNA-sequencing panel in the detection of gene fusions in solid tumors","volume":"23","author":"Sun","year":"2021","journal-title":"J. Mol. Diagn."},{"issue":"9","key":"10.1016\/j.leukres.2026.108237_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/PO-24-00788","article-title":"Challenging conventional diagnostic methods by comprehensive molecular diagnostics: a nationwide prospective comparison in children with ALL","author":"Boer","year":"2025","journal-title":"JCO Precis Oncol."},{"issue":"16","key":"10.1016\/j.leukres.2026.108237_bib27","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood.2019001244","article-title":"Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements","volume":"134","author":"Tanasi","year":"2019","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.leukres.2026.108237_bib28","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1182\/blood.2023023120","article-title":"Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain","volume":"143","author":"van Outersterp","year":"2024","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2026.108237_bib29","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1038\/s41375-021-01248-8","article-title":"Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia","volume":"35","author":"B\u04e7hm","year":"2021","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.leukres.2026.108237_bib30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.clml.2025.05.013","article-title":"A Phase I\/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and\/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia","volume":"25","author":"Goulart","year":"2025","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"7","key":"10.1016\/j.leukres.2026.108237_bib31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.pathol.2024.08.001","article-title":"Judicious use of precise fluorescence in situ hybridisation panels guided by population prevalence may assist pragmatic detection of clinically targetable Philadelphia chromosome-like acute lymphoblastic leukaemia fusions: a systematic review","volume":"56","author":"Thompson","year":"2024","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.leukres.2026.108237_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1182\/bloodadvances.2019000163","article-title":"Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"4","author":"Harvey","year":"2020","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.leukres.2026.108237_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41408-020-0313-6","article-title":"NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies","volume":"10","author":"Patkar","year":"2020","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.leukres.2026.108237_bib34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s12288-018-0997-y","article-title":"Keeping PACE with Ph Positive to Ph-Like Detection in B-Lineage Acute Lymphoblastic Leukemia: A Practical and Cost Effective (PACE) Approach in a Resource Constrained Setting","volume":"34","author":"Totadri","year":"2018","journal-title":"Indian J. Hematol. Blood Transfus."},{"issue":"3","key":"10.1016\/j.leukres.2026.108237_bib35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/10428194.2021.1999439","article-title":"PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of BCR-ABL1-like acute lymphoblastic leukaemia in Indian patients","volume":"63","author":"Gupta","year":"2022","journal-title":"Leuk. Lymphoma"},{"issue":"8","key":"10.1016\/j.leukres.2026.108237_bib36","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cncr.34665","article-title":"Genomic and proteomic characterization of Philadelphia-like B-lineage acute lymphoblastic leukemia: A report of Indian patients","volume":"129","author":"Gupta","year":"2023","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.leukres.2026.108237_bib37","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1002\/cncr.34957","article-title":"Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B-lineage acute lymphoblastic leukemia: A report of 1021 patients from India","volume":"129","author":"Gupta","year":"2023","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2026.108237_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40291-025-00775-9","article-title":"Bridging the Gap: cost-effective strategies for detecting Ph-like B-lineage ALL in resource-limited settings","volume":"29","author":"Gupta","year":"2025","journal-title":"Mol. Diagn. Ther."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:38:49Z","timestamp":1781051929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626000810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"alternative-id":["S0145212626000810"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108237","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of BCR::ABL1-like ALL using RT-PCR, a targeted RNA panel, and RNA sequencing","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108237"}}